Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR19034 eye drops for slowing myopia progression in children
CTR20212080Phase 3Completed
- Sponsor
- Chengdu Shengdi
- Start
- Oct 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myopia comparing HR19034 eye drops with HR19034 eye drops placebo (2 arms). Primary endpoint: Change from baseline in cycloplegic spherical equivalent refraction in the study eye. Started Oct 2021; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on CTR20212080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212080.